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ORIGINAL ARTICLE 
Development and evaluation of a safe and effective 
sugar-free herbal lollipop that kills cavity-causing bacteria
 
 
Chu-hong Hu1, Jian He1, Randal Eckert2, Xiao-yang Wu1, Li-na Li1, Yan Tian1, Renate Lux1, Justin A. Shuffer1, Faina 
Gelman1, Janet Mentes3, Sue Spackman1, Janet Bauer1, Maxwell H. Anderson2, Wen-yuan Shi1* 
 
1School of Dentistry, University of California, Los Angeles, USA; 2C3 Jian Inc, Inglewood, USA; 3UCLA School of 
Nursing, University of California, Los Angeles, USA  
Dental caries (tooth decay) is caused by a specific group of cariogenic bacteria, like Streptococcus mutans, 
which convert dietary sugars into acids that dissolve the mineral in tooth structure. Killing cariogenic bacteria 
is an effective way to control or prevent tooth decay. In a previous study, we discovered a novel compound 
(Glycyrrhizol A), from the extraction of licorice roots, with strong antimicrobial activity against cariogenic 
bacteria. In the current study, we developed a method to produce these specific herbal extracts in large 
quantities, and then used these extracts to develop a sugar-free lollipop that effectively kills cariogenic bacteria 
like Streptococcus mutans. Further studies showed that these sugar-free lollipops are safe and their antimicrobial 
activity is stable. Two pilot human studies indicate that a brief application of these lollipops (twice a day for ten 
days) led to a marked reduction of cariogenic bacteria in oral cavity among most human subjects tested. This 
herbal lollipop could be a novel tool to promote oral health through functional foods. 
Keywords: antimicrobial therapy; licorice; Streptococcus mutans 
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Introduction 
 
Dental caries (tooth decay) is a highly prevalent and 
costly disease in the United States and throughout the 
world. A recent Surgeon General’s report showed that 
45% of children aged 5-17 in the United States have 
varying levels of dental caries, and the report noted 
severe disease risk among children in underserved 
populations, such as Hispanic Americans and Native 
Americans [1]. Tooth decay is also increasing in inci- 
dence in the elder population of the United States [2]. 
Dental caries is an infectious disease dependent on a 
few species of cariogenic (cavity-causing) bacteria and 
specific dietary patterns (such as sugar intake and eating 
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frequency) [3-7]. Streptococcus mutans (S. mutans), Strep- 
tococcus sobrinus (S. sobrinus), and Lactobacillus casei 
(L. casei) are some of the well-known cavity-causing 
bacteria, while S. mutans is the major contributor to acid 
production [8-10]. Most cavity-causing bacteria colonize 
tooth surfaces and produce acids that dissolve tooth 
structures. Repeated dissolution events lead to cavitation 
and the subsequent need for repair of the damaged areas 
[11-13]. Given the fact that dental caries is an infectious 
disease, antimicrobial treatments against cavity-causing 
bacteria should help control or prevent tooth decay. 
Indeed, previous studies have shown that the applications 
of various antimicrobial agents to the oral cavity can 
reduce tooth decay. In this study, we investigated a licorice 
extract for its ability to kill cavity-causing bacteria. 
Licorice is the name applied to the roots and stolons 
of Glycyrrhiza species [14]. In a previous study, we 
generated a herbal extract from the roots of Glycyrrhiza 
uralensis, and the extract showed strong bacteriocidal 
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effects against cavity-causing bacteria like S. mutans. 
Further studies led to the discovery of a novel compound, 
Glycyrrhizol A, which is responsible for this bio-acti- 
vity [15]. In the current study, we aimed to produce the 
effective herbal extract in large quantity, and use this 
extract to develop a sugar-free lollipop that could effec- 
tively kill cavity-causing bacteria like S. mutans in vitro. 
We then ran safety, toxicity, stability and in vivo efficacy 
studies to verify the usefulness of this lollipop in killing 
cavity-causing bacteria in humans. 
 
Materials and Methods 
 
Production of effective licorice extracts in large quantity 
100 kg of licorice roots were cut into thin slices, 
soaked with 95% food grade ethanol in a 1∶8 ratio in 
extraction containers, and incubated at 37 ℃ for 72 h. 
The resulting ethanol solutions (containing extracts) were 
filtered three times. The extracts were then concentrated 
through ethanol evaporation and dried with a microwave 
“dry” distillation method, which is a combination of 
microwave heating and dry distillation, performed at 
atmospheric pressure. 
 
Chemical analysis of glycyrrhizol A within licorice extract 
with high performance liquid chromatography 
The quality of the herbal extracts was assayed with 
high performance liquid chromatography (HPLC, Amer- 
sham Biosciences, Sweden) for the amount of Glycyrr- 
hizol A. The HPLC conditions were: column, SOUR- 
CETM 15RPC (4.6/100); flow rate, 0.5 mL·min-1; elution 
system, H2O (0.1% TFA, solvent A) and CH3CN (0.1% 
TFA, solvent B); detector, UV 215, 260 and 280 nm; 
eluting gradient, from 10% (B) to 100% (B) in 15 CV 
(column volume, 1 CV = 1.662 mL). 
 
Analysis of residual pesticides, lead and arsenic within 
licorice extracts 
These studies were performed by Michelson Labo- 
ratories, Inc. The detailed protocols can be found at 
http://www.michelsonlab.com. 
 
Bacterial strains and culture growth conditions 
The following cavity-causing bacteria were used in 
the study: S. utans, strain UA159; S. sobrinus, strain 
ATCC27607; and, L. casei, strain ATCC334. All bacteria 
were grown at 37 ℃ in brain-heart infusion broth (BHI, 
Fisher) under anaerobic contions (90% N2, 5% CO2,  
5% H2). 
 
Determination of minimum inhibitory concentrations 
The antimicrobial activity of the licorice extract was 
first tested by microdilution broth assay based on the 
Clinical and Laboratory Standards Institute (CLSI) re- 
commended protocol. In general, an over-night bacterial 
culture was diluted to ~105 cfu·mL-1 with brain-heart 
infusion (BHI) and placed in a 96-well plate. Two-fold 
serial dilutions of licorice extracts were added to the 
96-well plate seeded with diluted bacteria and incubated 
for 18–24 h at 37 ℃ under anaerobic conditions. The 
minimum inhibitory concentration (MIC) was deter- 
mined as the concentration of licorice presenting in the 
first clear well. 
 
Creation of sugar-free herbal lollipop with licorice extracts 
A standard sugar-free candy formula from Dr. John’s 
Candy (http://www.drjohns.com/) was used for making 
the herbal lollipop. The main ingredients were: hydro- 
genated starch hydrolysate (HSH) (solidifying agent), 
citric acid and mint (flavoring agents), FD & C blue #1,2; 
Red 3, 40; Yellow 5, 6 (coloring agents), and acesulfame 
potassium (noncaloric sweetener). Depending on the 
concentration of Glycyrrhizol A in a batch of licorice 
extract, 7 to 15 mg of licorice extracts were added to 
each lollipop to achieve a uniform concentration of 
Glycyrrhizol A. 
The lollipop making process involves various tem- 
peratures from 135 ℃ cooked syrup to 65 ℃ on the 
cooling table. Thermal stability of Glycyrrhizol A at 
various temperatures was tested and herbal extracts were 
added at temperatures that did not affect their bio- 
activities. 
 
Testing bioactivity of herbal lollipops against cavity- 
causing bacteria 
The bioactivities of herbal lollipops against cavity- 
causing bacteria were analyzed with two assays: over- 
night growth inhibition and time killing assay. 
For the overnight growth inhibition study, a lollipop 
(~10 g/piece) was broken into powder by a high speed 
pulverizing machine and dissolved in 10 mL BHI broth, 
then mixed with a bacterial testing solution 1∶1 to final 
OD600=0.1. After 12 hours of incubation, OD600 was 
measured again to indicate the inhibitory effects against 
bacterial growth. 
For the time killing assay, solutions derived from the 
herbal lollipop and the placebo lollipop were prepared. A 
cariogenic S. mutans strain was grown into log phase 
under anaerobic conditions overnight, and diluted with 
BHI growth medium to ~106 mL-1. The bacterial culture 
was then mixed with the different solutions described 
above at a ratio 1∶10 and incubated for 1, 5, and 10 min, 
respectively. The incubated mixtures were rescued in 
large volume of BHI broth, and then plated on BHI agar 
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plates, incubated overnight at 37 ℃, and counted for 
surviving bacteria.  
 
Studying the stability of the herbal lollipops 
The herbal lollipops were placed at 25, 37, and 60 ℃ 
incubators for various times and then examined for their 
antimicrobial activities against cariogenic bacteria using 
the overnight growth inhibition and time killing assays 
described above. 
 
Studying the safety of the herbal lollipops 
Genotoxicity of licorice extract was examined with 
the Ames tests [16] using Salmonella typhimurium TA 
1535 (His deficiency) (ATCC 29629), TA1537 (His defi- 
ciency) (ATCC 29630), and Escherichia coli WP2 uvrA 
(Trp deficiency) (ATCC 49979). 
Cytotoxicity of licorice extract was examined with 
Promega’s CellTiterGlo assay using various epithelial 
and immune cell lines: Jurkat, HOK68, CHO and BHK. 
The safety of the licorice extract was also examined 
with single dose acute toxicity study with mice. In these 
studies, licorice extract was orally administered via 
pipette for 45 s for each mouse (holding the neck to 
reduce swallowing). Each mouse received 3 mg in a 
100 µL volume in 20 µL increments, which they would 
swallow intermittently. The 45 s treatment time refers to 
the time that mice harbored a visible volume of licorice 
extract prior to swallowing. Mice were visually observed 
for oral irritation changes of behavior daily following 
treatment. Mice were also weighed weekly for aberrant 
weight fluctuations. Two weeks post-treatment, the mice 
were euthanized for pathological examination on major 
organs (heart, liver, spleen, intestines, stomach, kidney 
and lung). 
 
Protocols for pilot human studies 
Two pilot human studies were authorized by UCLA 
IRB committee and performed using identical protocols. 
The two studies were of 10-day duration, involving a 
total of 26 subjects at different ages. There were two 
study visits, including the initial screening/baseline visit 
over the 10-day study period (baseline and 10 days). All 
visits were scheduled in the morning before lunch. 
At the baseline visit, after affirmative completion of 
the informed consent process and all necessary forms, 
each subject underwent a visual and photographic cli- 
nical oral examination. For those subjects who visually 
met the study criteria, a saliva sample was obtained. At 
total of 0.5 mL of saliva was collected and placed in the 
provided 1.5 mL Eppendorf tube. These samples were 
used to measure the amount of S. mutans present, using 
the monoclonal antibody based S. mutans detection 
method described below [17]. To qualify for the study, 
subjects had to have a minimum of 1.0 × 105 S. mutans 
cells/mL in their saliva samples. 
Once the bacterial samples (saliva) were analyzed, we 
notified all subjects of their qualification status. Quali- 
fied subjects were given oral and written product use 
instructions. All human subjects were provided with 20 
lollipops. After using the products for 10 days, the 
subjects attended a morning appointment. Subjects were 
asked about any adverse events they may have expe- 
rienced since the previous visit. They then provided 
samples of their saliva and a visual examination of their 
mouth was performed to assess the status of the oral 
tissues. Data were analyzed using various statistical 
methods, as presented in the Results. 
 
Analysis of salivary S. mutans using species-specific 
monoclonal antibody 
At total of 10 mL of saliva sample fixed with 1% 
formaldehyde was incubated with 10 mL purified anti- 
S. mutans monoclonal antibody for 30 min, and then 
0.5 mL FITC labeled anti-mouse IgG (Sigma, USA) was 
added to the mixture and incubated for another 1 h. 
10 mL of the above mixed sample was then checked 
under a florescent microscope (Nikon eclipse E400, 
Japan). 
 
Results 
 
Producing large quantity licorice extracts with strong 
antimicrobial activity against cavity-causing bacteria 
Following our previous discovery [15] that a specific 
licorice extract has strong antimicrobial activity against 
cavity-causing bacteria due to the existence of a highly 
potent antimicrobial compound, Glycyrrhizol A, we aimed 
to develop a sugar-free candy supplemented with licorice 
extracts to promote oral health. In order to achieve this 
goal, we first needed to produce effective licorice extracts 
in large quantity, and in a safe manner. 
In collaboration with a Chinese manufacturer specia- 
lized in herbal extraction, we collected five different 
licorice root samples harvested from different parts of 
China (Zhejiang, Jiangsu, Gansu, Xingjiang and Inner 
Mongolia provinces), cut licorice roots into different 
shapes (thin slices, small rods, or ground powders), and 
used different extraction methods (such as water boiling 
or ethanol soaking) for different periods of time. Most 
importantly, instead of using toxic organic solvents 
described in the previous paper [15], we successfully 
developed a new protocol to achieve the same effect by 
using food-grade ethanol. 
The licorice extract produced in large quantity was 
www.ijos.org.cn | International Journal of Oral Science 
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chemically analyzed with HPLC. As shown in Figure 1, 
the extract did contain high levels of Glycyrrhizol A. 
Additional chemical analyses indicated that the extract 
had no detectable pesticides, lead, orarsenic (Table 1). 
We examined the anti-microbial activity of this large- 
scale prepared licorice extract. As shown in Table 2, the 
extract had strong antimicrobial activity against the 
major cavity-causing bacteria, as the MIC against these 
bacteria are less than 40 μg·mL-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 HPLC analysis of Glycyrrhizol A within licorice extract. Glycyrrhizol A is detected by Amersham Bio- 
sciences HPLC with UV 215 at retention volume 19.65 mL. 
 
Table 1 Analysis of hazard chemicals within the licorice 
extract (performed by Michelson Laboratories, Commerce, 
CA) 
Testing item Results 
Lead Not detected 
Arsenic Not detected 
Organo-halide pesticides Not detected 
Organo-phosphate pesticides Not detected 
Carbamate pesticides Not detected 
 
Table 2 MIC of large scale prepared herbal extracts against 
major cavity-causing bacteria                   g·mL-1 
Tested cavity-causing bacteria MIC* 
S. mutans 15.6 
S. sobrinus 31.2 
L. casei 31.2 
*MIC: represents average of at least three independent 
experiments. 
 
Developing a sugar-free herbal lollipop with bacteri- 
cidal effects against cavity-causing bacteria 
With large-scale production of effective herbal extracts 
accomplished, we began to consider the best methods to 
deliver this active antimicrobial herbal extract to the oral 
cavity. After extensive discussion, we decided to create a 
sugar-free candy, supplemented with the herbal extract 
as the carrier to deliver the naturally occurring anti- 
microbial component. The rationale was that we could 
deliver the antimicrobial components through the same 
mechanism that causes the problem of dental caries, i.e. 
use a behavioral pattern that causes the problem (candy 
consumption) to solve the problem. This strategy allows 
access to the at-risk population without demanding 
behavior changes. Among different forms of candies, we 
chose lollipops, since they are the acceptable and safe 
delivery mechanisms welcomed by children, seniors, and 
other needy populations, such as the severely disabled. 
Furthermore, the act of sucking on lollipops helps 
stimulate salivary production to advantage reminerali- 
zation, and because of the volume and dissolution rate, 
the teeth get maximum exposure time to the herbal 
extracts. This adds substantivity to the delivery system 
since it takes longer (10–15 min) to dissolve a lollipop 
compared with other candy forms we tested. 
In collaboration with Dr. John’s Candies, we went 
through a number of different formulations and produc- 
tion procedures to develop a formula in which the herbal 
extracts were mixed with candy syrup at a temperature 
and duration that does minimal damage to their bio- 
activity, and ensured that a sufficient amount of herbal 
extract was added to each lollipop to guarantee its 
bioactivity. The currently marketed lollipop is the fini- 
shed product of this study. It is worthwhile noting that, 
depending on the concentration of the active ingredient 
in different batches, herbal extracts have MICs against 
                                   Chu-hong Hu et al. 
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the major cavity-causing bacteria ranging from 13– 
40 g·mL-1. After testing, an adjusted amount of herbal 
extracts (from 7–15 mg) are added to each lollipop to 
ensure final herbal concentrations in oral cavity are 
around 25× higher than the MIC, since it takes about 
10–15 min (with the production of 10–15 mL saliva) [7] 
to dissolve a lollipop (about 10 g). The actual data on the 
efficacy and stability of the herbal lollipops are descri- 
bed below. 
 
Studying in vitro efficacy and stability of herbal lollipops 
The in vitro antimicrobial activity of the herbal 
lollipop was first assayed with an overnight growth 
inhibition assay. As shown in Table 3, herbal lollipops 
exhibited good antimicrobial activities against the mea- 
sured cavity-causing bacteria, indicating that herbal extracts 
embedded in the lollipops retained their antimicrobial  
bioactivities. 
Since these data were obtained by incubating the 
bacteria with lollipop solutions overnight, while a lolli- 
pop dissolves in the oral cavity in 10–15 min, a direct 
comparison study was performed to determine if expo- 
sure to an herbal lollipop would kill the cavity-causing 
bacteria in 10–15 min. Given a stimulated human salivary 
flow rate of approximately 1 mL·min-1 [7], a lollipop 
was dissolved in a 10–15 mL solution and tested for its 
bactericidal activity after 15 min, in comparison with 
placebo lollipops. As shown in Figure 2, the herbal 
lollipop exhibited significantly better antimicrobial acti- 
vities against cavity-causing bacteria compared to the 
placebo lollipops. 
Both the overnight growth inhibition and time killing 
assays are routinely used to test each freshly made batch 
of herbal lollipops to ensure their quality. 
We also ran an extensive stability study of the herbal 
lollipops by placing them at 25, 37, and 60 ℃ incubators 
for various times and then examined their antimicrobial 
activities against cavity-causing bacteria using both the 
overnight growth inhibition and time killing assays des- 
cribed above. No significant reduction in bioactivities 
was observed in nine months. 
 
Examining the safety of the herbal lollipop 
All ingredients used in the sugar-free lollipops are 
FDA-approved for human consumption. Licorice has 
been used by various cultures for thousands of years, 
and many previous studies have shown that it is a safe 
medicinal herb [18-19]. FDA lists licorice as GRAS 
(generally regarded as safe) when used as a food fla- 
voring or sweetening agent. 
 
Table 3 Antimicrobial activity of the herbal lollipop 
Tested cavity-causing bacteria OD600 after 12 h with placebo lollipop OD600 after 12 h with herbal lollipop
S. mutans 1.5 0.1 
S. sobrinus 1.7 0.1 
L. casei 1.4 0.1 
Lollipop (~10 g) with or without licorice extract is dissolved in 10 mL solution and mixed with bacterial solution 1∶1. 
Initial OD600 reading is 0.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Time killing assay. Bioactivity of lollipops against cavity-causing bacteria S. mutans planktonic cells. 
Diluted S. mutans were exposed to TH broth (group I), 0.125 g·mL-1 lollipop placebo (group II), 0.25 g·mL-1 herbal 
lollipop (group III) and 1 g·mL-1 herbal lollipop (group IV) for 1, 5, and 10 min. Survival rates (%) were calculated by 
dividing surviving CFU per milliliter of each lollipop solution by surviving CFU per milliliter of TH broth. Data 
represents averages of the results of three independent experiments. 
www.ijos.org.cn | International Journal of Oral Science 
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Table 4 Summary of toxicity/safety studies on the licorice extract 
The performed toxicity/safety tests The results 
Ames tests using S. typhimurium TA1535 (His deficiency) (ATCC 29629), S. 
typhimurium TA1537 (His deficiency) (ATCC 29630) and Escherichia coli WP2 
uvrA (Trp deficiency) (ATCC 49979) 
No genotoxicity was detected 
Cytotoxicity study with Promega’s CellTiterGlo assay using cell lines of Jurkat, 
HOK68, CHO and BHK 
No cellular toxicity was detected 
Single dose acute toxicity study with mice on oral irritation, behavioral changes, and 
pathological examination on major organs (heart, liver, spleen, intestines, stomach, 
kidney, and lung) 
No animal toxicity was detected 
 
Table 5 Pilot human study: salivary S. mutans analysis before and after herbal lollipop treatment 
Subjects Baseline After treatment Subjects Baseline After treatment 
1 6.67 × 105 1.33 × 106 14 3.70 × 107 3.82 × 107 
2 1.67 × 106 4.00 × 105 15 2.00 × 106 1.24 × 105 
3 3.33 × 105 3.33 × 105 16 7.40 × 105 2.40 × 107 
4 3.00 × 105 1.33 × 105 17 1.80 × 105 1.35 × 105 
5 2.33 × 105 1.00 × 105 18 0.00 2.68 × 107 
6 1.00 × 105 1.33 × 104 19 1.30 × 106 2.51 × 105 
7 6.00 × 105 3.33 × 104 20 2.30 × 107 2.02 × 105 
8 4.26 × 107 1.00 × 104 21 1.00 × 107 1.10 × 105 
9 3.00 × 107 1.44 × 105 22 4.09 × 107 2.91 × 105 
10 5.00 × 107 9.12 × 104 23 1.00 × 107 2.26 × 105 
11 3.70 × 106 0.00  24 1.00 × 107 1.00 × 105 
12 1.48 × 106 2.40 × 105 25 3.72 × 105 1.40 × 105 
13 8.00 × 105 1.71 × 105 26 1.24 × 105 0.00 
All numbers represent S. mutans counts in 1 mL saliva. 0.00 is a statistical readout which indicates S. mutans is undetectable 
due to current experimental method limitation. 
Since the original raw data do not distribute normally, the statistical analysis was performed on log scale with proc t-test using 
SAS version 9 (SAS Institute Inc., Cary, NC). P-value for testing difference (Normally distributed): 0.853 5; Mean difference: 
log (after) – log (before): -2.41; Standard error of mean difference: 0.549 7; t-test statistic: -4.38; Number of before/after pairs 
both having values: 23; P-value for testing mean difference is 0: 0.000 2. 
 
We performed additional safety tests on the herbal 
lollipops, including the Ames test based genotoxicity 
study, CellTiterGlo based cytotoxicity studies, and acute 
animal toxicity studies, as described in the Materials and 
Methods. As shown in Table 4, all toxicity studies had 
negative outcomes, further confirming the safety of this 
herbal lollipop. 
 
Verifying the in vivo efficacy of herbal lollipop for its 
ability to kill cavity-causing bacteria in human oral 
cavity 
Approved by the UCLA IRB committee, we per- 
formed two pilot human studies at UCLA Children’s 
Dental Clinic (20 subjects) and two Los Angeles nursing 
homes (6 subjects). Due to the limited number of human 
subjects, no control groups were used for these initial 
studies. Instead, all subjects were initially tested for 
salivary S. mutans using a monoclonal antibody based 
test [17], then exposed to the lollipops for ten days 
(twice a day) before repeat testing for salivary S. mutans. 
As shown in Table 5, and consistent with in vitro studies, 
a majority of subjects exhibited dramatic reductions of 
salivary S. mutans after using the lollipop. 
 
Discussion 
 
This study describes the development of an herbal 
lollipop that can kill cavity-causing bacteria. The studies 
showed that these sugar-free lollipops are safe and their 
antimicrobial activities are stable in the formulations 
intended for delivery. Two pilot human studies indicated 
that a brief application of these lollipops (twice a day for 
10 days) led to marked reduction of cavity-causing 
bacteria in oral cavity among most of the human subjects 
International Journal of Oral Science | Vol 3 No 1| January 2011 
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tested [20-21]. We recognize that while the data from 
pilot human studies are encouraging, they are preliminary. 
In the future, we plan to design double-blind, rando- 
mized, longitudinal studies that include more human 
subjects and more examination points, to give us better 
data about the lollipop’s long term efficacy. We also plan 
to do more detailed studies on how soon the cavity- 
causing bacteria grow back after treatment, why there 
are variable results among some people, and how 
frequently the herbal lollipops should be used to achieve 
maximum protective effects. From the basic science 
perspective, we are interested in learning the killing 
mechanism(s) by which Glycyrrhizol A exerts its effects 
and how likely a cavity-causing bacterial cell is to 
develop the resistance against the compound. We speci- 
fically applied the herbal lollipop in a dosing regimen 
(twice per day for 10 days) designed to preclude the 
development of resistant forms. The regimen was also 
structured to minimize the costs to purchasing entities, 
so that this system might be used in public health 
settings. Rather than applying the herbal lollipop as a 
low-dose, long-term strategy (increasing cost and the 
opportunity for resistance), a short-term, intensive strategy 
was employed. This is consistent with the evolving science 
concerning biofilms and their adaptation to metabolic 
and antimicrobial pressures.  
Previous studies have shown a clear connection 
between killing cavity-causing bacteria and reductions in 
tooth decay. Since the killing effect against cavity- 
causing bacteria of this herbal lollipop is evident, use of 
this lollipop may lead to control or prevention of tooth 
decay, making it a novel tool to promote oral health as a 
functional food for special dietary use. However, we still 
need to demonstrate this anticavity effect clinically, 
rather than just via the microbiology end-point. 
In our preliminary studies, we found that licorice 
extract did not interfere with the activity of other anti- 
cavity components such as fluoride and xylitol. It may 
be interesting to study the possible synergistic effects 
between and amongst these ingredients. Lollipops turn 
out to be a useful delivery device welcomed by different 
populations with problems in oral cavity. One could 
consider using it as a delivery device to treat other 
diseases in oral cavity and gastrointestinal tract. 
Finally, the application of lollipop helps to promote 
oral health, but does not replace current dental pre- 
ventive strategies like tooth brushing and fluoride appli- 
cations provided by dental offices. 
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